The high post-test probability of a cytological examination renders further investigations to establish a diagnosis of epithelial malignant pleural mesothelioma redundant

Diagnostic Cytopathology

Volumn 34, Issue 8, 2006, Pages 523-527

  Aerts, J G J V ^a,c   Delahaye, M ^a   Van Der Kwast, T H ^a,d   Davidson, B ^b   Hoogsteden, H C ^a   Van Meerbeeck, J P ^a,e  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF OSLO   (Norway)

^c Sint Franciscus Gasthuis ^*  (Netherlands)

^d MOUNT SINAI HOSPITAL   (Canada)

^e GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Cytology; Immunocytochemistry; Mesothelioma; Pleural effusion

Indexed keywords

CARCINOEMBRYONIC ANTIBODY; EPITHELIAL MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY BER EP4; MONOCLONAL ANTIBODY EMA; MONOCLONAL ANTIBODY TAG72; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADULT; ARTICLE; BAYES THEOREM; CANCER CYTODIAGNOSIS; CANCER DIAGNOSIS; CELL STRUCTURE; CLINICAL ARTICLE; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; ELECTRON MICROSCOPY; EVIDENCE BASED MEDICINE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; PLEURA; PLEURA EFFUSION; PLEURA FLUID; PLEURA MESOTHELIOMA; PLEURISY; PRIORITY JOURNAL; PROBABILITY;

BAYES THEOREM; CYTODIAGNOSIS; EPITHELIUM; HUMANS; IMMUNOHISTOCHEMISTRY; MESOTHELIOMA; MICROSCOPY, ELECTRON; PLEURAL NEOPLASMS; PROSPECTIVE STUDIES;

EID: 33746605601     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.20486     Document Type: Article

References (27)

1. Whitaker D. The cytology of malignant mesothelioma. Cytopathology 2000;11:139-151.
2. Sherman ME, Mark EJ. Effusion cytology in the diagnosis of malignant epitheloid and biphasic pleural mesothelioma. Arch Pathol Lab Med 1990;114:845-851.
3. Renshaw AA, Dean BR, Antman KH, Sugarbaker DJ, Cibas ES. The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma. Chest 1997;111:106-109.
4. Brockstedt U, Gulyas M, Dobra K, Dejmek A, Hjerpe A. An optimised battery of eight antibodies that can distinguish most cases of epithelial mesothelioma from adenocarcinoma. Am J Clin Pathol 2000;114:203-209.
5. Chieng DC, Yee H, Schaefer D, Cangiarella JF, Chiriboga LA, Cohen J-M. Calretinin staining patter aids in the differentiation of mesothelioma from adenocarcinoma in serous effusions. Cancer Cytopathol 2000;90:194-200.
6. Martenson G, Hangmar B, Zettergren L. Diagnosis and prognosis in malignant pleural mesothelioma. A prospective study. Eur J Respir Dis 1984;65:169-178.
7. Sackett DL, Straus SE, Richardson WS, Rosenberg W, Haynes RB, editors. Evidence-based medicine. 2nd ed. Edinburgh: Churchill Livingstone; 2000. p 67-93.
8. Paganuzzi M, Onetto M, Marroni P, et al. Diagnostic value of CYFRA 21-1 tumor marker and CEA in pleural effusion due to mesothelioma. Chest 2001;119:1138-1142.
9. Van der Kwast TH, Versnel MA, Delahaye M, Jong de A, Zondervan PE, Hoogsteden HC. Expression of epithelial membrane antigen on malignant mesothelioma cells. Acta Cytol 1988;32: 169-174.
10. Cury PM, Butcher DN, Corrin B, Nicholson AG. The use of histological and immunohistochemical markers to distinguish pleural malignant mesothelioma and in situ mesothelioma from reactive mesothelial hyperplasia and reactive pleural fibrosis. J Pathol 1999; 189:251-257.
11. Stirling JW, Henderson DW, Spagnolo DV, Whitaker D. Unusual granular reactivity for carcinoembryonic antigen in malignant mesothelioma. Hum Pathol 1990;21:678-679.
12. Delahaye M, Hoogsteden HC, van der Kwast TH. Immunocytochemistry of malignant mesothelioma: OV632 as a marker of malignant mesothelioma. J Pathol 1991;165:137-143.
13. Fetsch PA, Abati A. Immunocytochemistry in effusion cytology. A contemporary review. Cancer Cytopathol 2001;93:293-308.
14. Roberts F, Harper CM, Downie I, Burnett RA. Immunohistochemical analysis still has a limited role in the diagnosis of malignant mesothelioma. Am J Clin Pathol 2001;116:253-262.
15. Ordonez NG. Value of calretinin immunostaining in differentiating epithelial mesotehioma from lung adenocarcinoma. Mod Pathol 1998;11:929-933.
16. Delahaye M, Van der Ham F, Van der Kwast TH. Complementary value of five carcinoma markers for the diagnosis of malignant mesothelioma, adenocarcinoma metastasis, and reactive mesothelium in serous effusions. Diagn Cytopathol 1997;17:115-120.
17. Ordonez NG, Mackay B. Electron microscopy in tumor diagnosis: Indications for its use in the immunohistochemical era. Hum Pathol 1998;12:1403-1411.
18. Oury TD, Hammar SP, Roggli VL. Ultrastructural features of diffuse malignant mesothelioma. Hum Pathol 1998;29:1382-1392.
19. Segura O, Burdorf A, Looman C. Update of predictions of mortality from pleural mesothelioma in the Netherlands. Occup Environ Med 2003;60:50-55.
20. Peto J, Decarli A, La Vecchia C, Levi F, Negri E. The European mesothelioma epidemic. Br J Cancer 1999;79:666-672.
21. Vogelenzang NJ, Rusthoven JJ, Symanowski J, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003;21:2636-2644.
22. Ordonez NG. The immunohistochemical diagnosis of mesothelioma. Am J Surg Pathol 2003;27:1031-1051.
23. Fetsch PA, Simsir A, Abati A. Comparison of antibodies to HBME-1 and calretinin for detection of mesothelial cells in effusion cytology. Diagn Cytopathol 2001;25:158-161.
24. Simsir A, Fetsch P, Mehta D, Zakowski M, Abati A. E-cadherin, N-cadherin and calretinin in pleural effusions. Diagn Cytopathol 1999; 20:125-130.
25. Davidson B, Nielsen S, Christensen J, et al. The role of desmin and N-cadherin in effusion cytology: A comparative study using established markers of mesothelial and epithelial cells. Am J Surg Pathol 2001;25:1405-1412.
26. Wolanski KD, Whitaker D, Shilkin KB, et al. The use of epithelial membrane antigen and silver-stained nucleolar organizer regions testing in the differential diagnosis of mesothelioma from benign reactive mesothelioses. Cancer 1998;82:583-590.
27. Churg A, Colby TV, Cagle P, et al. The separation of benign and malignant mesothelial proliferations. Am J Surg Pathol 2000;24: 1183-2000.